Sharing of data from clinical trials provides the opportunity to improve the value and integrity of data analyses, but there are risks, and the primary duty for responsible reporting should reside with the investigators.
This is a preview of subscription content, log in via an institution to check access.
References
Jones, C. W. et al. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ 347, f6104 (2013).
Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. (National Academies Press, 2015).
Taichman, D. B. et al. Sharing clinical trial data — a proposal from the International Committee of Medical Journal Editors. N. Engl. J. Med. 374, 384–386 (2016).
Academic Research Organization Consortium for Continuing Evaluation of Scientific Studies — Cardiovascular (ACCESS CV). Sharing data from cardiovascular clinical trials — a proposal. N. Engl. J. Med. 375, 407–409 (2016).
International Consortium of Investigators for Fairness in Trial Data Sharing. Toward fairness in data sharing. N. Engl. J. Med. 375, 405–407 (2016).
Ohman, E. M. & Roe, M. T. Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany “Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified” (Thromb Haemost 2011; 105.5). Thromb. Haemost. 105, 763–765 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Granger, C., Ohman, E. Enhancing the value of clinical trials: the role of data sharing. Nat Rev Cardiol 13, 629–630 (2016). https://doi.org/10.1038/nrcardio.2016.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2016.146
- Springer Nature Limited